PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
33 hedge funds and large institutions have $25.5M invested in PLx Pharma Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more funds holding
Funds holding: 33 → 33 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
7% less capital invested
Capital invested by funds: $27.5M → $25.5M (-$2.02M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$1.65M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$952K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$341K |
| 4 |
TCM
Timpani Capital Management
Milwaukee,
Wisconsin
|
+$217K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$137K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$4.56M |
| 2 |
TCP
Tourbillon Capital Partners
New York
|
-$1.35M |
| 3 |
LSVM
Lone Star Value Management
Old Greenwich,
Connecticut
|
-$392K |
| 4 |
Goldman Sachs
New York
|
-$362K |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$135K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $15K | +$16.8K | +194 | New |
|
|
BIM
27
BlackRock Investment Management
Wilmington,
Delaware
| $9K | +$693 | +8 | +7% |
|
28
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $6K | -$1.21K | -14 | -16% |
|
29
UBS Group
Zurich,
Switzerland
| $5K | – | – | – |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $3K | -$520 | -6 | -14% |
|
|
ASN
31
Advisory Services Network
Atlanta,
Georgia
| $3K | – | – | – |
|
|
FANJ
32
Financial Architects (New Jersey)
Marlton,
New Jersey
| $3K | – | – | – |
|
33
Bank of America
Charlotte,
North Carolina
| $1K | +$87 | +1 | +14% |
|
|
SIP
34
Stoneridge Investment Partners
Radnor,
Pennsylvania
| – | -$98K | -1,289 | Closed |
|
|
SCA
35
Stonebridge Capital Advisors
St Paul,
Minnesota
| – | -$95K | -1,250 | Closed |
|
36
New York State Common Retirement Fund
Albany,
New York
| – | -$54K | -713 | Closed |
|
PLXP Hedge Fund Activity: Q2 2016 in Review
33 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2016, worth a combined $25.5M — down 7.3% from $27.5M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PLXP positions and 4 closed out — a net gain of 1 holder — while 11 added to existing stakes and 11 trimmed.
The largest buyer was Lombard Odier Asset Management (USA), opening a new position worth an estimated $1.65M. The largest seller was Broadfin Capital, cutting an estimated $4.56M.
- 33 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $25.5M of PLx Pharma Inc. Common Stock stock for Q2 2016, down 7.3% quarter-over-quarter.
- 5 funds opened new PLx Pharma Inc. Common Stock positions in Q2 2016 and 4 closed out, a net change of +1 holder.
- The largest PLx Pharma Inc. Common Stock buyer in Q2 2016 was Lombard Odier Asset Management (USA), an estimated $1.65M added.
- The largest PLx Pharma Inc. Common Stock seller in Q2 2016 was Broadfin Capital, an estimated $4.56M sold.
Based on aggregated 13F filings for Q2 2016.